Across TCGA pan-cancer cohorts, ARIH2OS Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ARIH2OS data layer compared with 25 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher ARIH2OS Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ARIH2OS expression acts as an unfavorable survival marker.

COAD are the cancer types where ARIH2OS Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.113	0.806	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: ARIH2OS tumor-vs-normal RNA expression · all ARIH2OS data types